Schedule 13G ownership disclosure

AKARI THERAPEUTICS PLC

Ordinary shares, $0.000000005 par value · CUSIP: 00972G207

Event date: 2026-03-02

Filing-level shares
18,199,697,667.00
Percent of class
18.4%
  • Hoyoung Huh, M.D., Ph.D.

    Shares: 18,199,697,667.00 · Class: 18.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-008873
Form type
SCHEDULE 13G/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Mar 04, 2026
Reporting period
Mar 02, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub